Stealth Biotherapeutics Shares Rebound From Session Low On Spike In Volume Following Circulation Of FDA AccessData.gov Listing For Co.’s Duchenne Muscular Dystrophy Treatment, Shows Co Designation For Orphan Designation
https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=874722
